Skip to main content
Erschienen in: Neurocritical Care 2/2008

01.10.2008 | Original Article

Packed Red Blood Cell Transfusion Causes Greater Hemoglobin Rise at a Lower Starting Hemoglobin in Patients with Subarachnoid Hemorrhage

verfasst von: Andrew M. Naidech, Marc J. Kahn, Wayne Soong, David Green, H. Hunt Batjer, Thomas P. Bleck

Erschienen in: Neurocritical Care | Ausgabe 2/2008

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Each unit of packed red blood cells (PRBCs) is expected to raise circulating hemoglobin (HGB) by ∼1 g/dL. There are few data on modifiers of this relationship other than gender and body mass index (BMI).

Methods

We recorded HGB before and after PRBC transfusion in a retrospective cohort of 103 patients and a prospective cohort of 93 patients with subarachnoid hemorrhage (SAH).

Results

In the retrospective cohort, 48 of 103 patients were transfused, and in the prospective cohort, 56 of 93 patients were transfused. In both groups, lower pre-transfusion HGB was associated with a larger increase in HGB (P < 0.001) after correction for the number of units of PRBCs given. In the prospective cohort, lower pre-transfusion HGB was associated with a greater rise in HGB (P < 0.001) after correction for number of units of PRBCs given, gender, and BMI in repeated measures analysis. Pre-transfusion HGB explained an additional 12% of variance in the data (P < 0.001). In both cohorts, the magnitude of the effect was similar.

Conclusion

In patients with SAH, transfusion at lower HGB leads to a greater increase in HGB. Transfusion at lower HGB may be relatively more cost-effective, and this should be balanced against any potential benefit from higher HGB in SAH. One rather than 2 units of PRBCs are likely to be sufficient for most HGB targets after SAH, especially in patients with more severe anemia.
Literatur
1.
Zurück zum Zitat von Ahsen N, Muller C, Serke S, Frei U, Eckardt KU. Important role of nondiagnostic blood loss and blunted erythropoietic response in the anemia of medical intensive care patients. Crit Care Med. 1999;27:2630–9.CrossRef von Ahsen N, Muller C, Serke S, Frei U, Eckardt KU. Important role of nondiagnostic blood loss and blunted erythropoietic response in the anemia of medical intensive care patients. Crit Care Med. 1999;27:2630–9.CrossRef
2.
Zurück zum Zitat Rodriguez RM, Corwin HL, Gettinger A, Corwin MJ, Gubler D, Pearl RG. Nutritional deficiencies and blunted erythropoietin response as causes of the anemia of critical illness. J Crit Care. 2001;16:36–41.PubMedCrossRef Rodriguez RM, Corwin HL, Gettinger A, Corwin MJ, Gubler D, Pearl RG. Nutritional deficiencies and blunted erythropoietin response as causes of the anemia of critical illness. J Crit Care. 2001;16:36–41.PubMedCrossRef
3.
Zurück zum Zitat Burnum JF. Medical vampires. N Engl J Med. 1986;314:1250–1.PubMed Burnum JF. Medical vampires. N Engl J Med. 1986;314:1250–1.PubMed
4.
Zurück zum Zitat Corwin HL, Krantz S. Anemia in the critically ill: “acute” anemia of chronic disease. Crit Care Med. 2000;28:3098–9.PubMedCrossRef Corwin HL, Krantz S. Anemia in the critically ill: “acute” anemia of chronic disease. Crit Care Med. 2000;28:3098–9.PubMedCrossRef
5.
Zurück zum Zitat Adam RC, Lundy JS. Anesthesia in cases of poor risk: some suggestions for decreasing the risk. Surg Gynecol Obstet. 1942;74:1011–101. Adam RC, Lundy JS. Anesthesia in cases of poor risk: some suggestions for decreasing the risk. Surg Gynecol Obstet. 1942;74:1011–101.
6.
Zurück zum Zitat Hebert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. New Engl J Med. 1999;340:409–17.PubMedCrossRef Hebert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. New Engl J Med. 1999;340:409–17.PubMedCrossRef
7.
Zurück zum Zitat Corwin HL, Gettinger A, Pearl RG, et al. The CRIT study: anemia and blood transfusion in the critically ill-current clinical practice in the United States. Crit Care Med. 2004;32:39–52.PubMedCrossRef Corwin HL, Gettinger A, Pearl RG, et al. The CRIT study: anemia and blood transfusion in the critically ill-current clinical practice in the United States. Crit Care Med. 2004;32:39–52.PubMedCrossRef
8.
Zurück zum Zitat Naidech AM, Drescher J, Ault ML, Shaibani A, Batjer HH, Alberts MJ. Higher hemoglobin is associated with less cerebral infarction, poor outcome, and death after subarachnoid hemorrhage. Neurosurgery 2006;59:775–80.PubMedCrossRef Naidech AM, Drescher J, Ault ML, Shaibani A, Batjer HH, Alberts MJ. Higher hemoglobin is associated with less cerebral infarction, poor outcome, and death after subarachnoid hemorrhage. Neurosurgery 2006;59:775–80.PubMedCrossRef
9.
Zurück zum Zitat Naidech AM, Jovanovic BJ, Wartenberg KE, et al. Higher hemoglobin is associated with improved outcome after subarachnoid hemorrhage. Crit Care Med. 2007;35:2383–9.PubMedCrossRef Naidech AM, Jovanovic BJ, Wartenberg KE, et al. Higher hemoglobin is associated with improved outcome after subarachnoid hemorrhage. Crit Care Med. 2007;35:2383–9.PubMedCrossRef
10.
Zurück zum Zitat Egge A, Waterloo K, Sjøholm H, Solberg T, Ingebrigtsen T, Romner B. Prophylactic hyperdynamic postoperative fluid therapy after aneurysmal subarachnoid hemorrhage: a clinical, prospective, randomized, controlled study. Neurosurgery 2001;49:593–606.PubMedCrossRef Egge A, Waterloo K, Sjøholm H, Solberg T, Ingebrigtsen T, Romner B. Prophylactic hyperdynamic postoperative fluid therapy after aneurysmal subarachnoid hemorrhage: a clinical, prospective, randomized, controlled study. Neurosurgery 2001;49:593–606.PubMedCrossRef
11.
Zurück zum Zitat Katayama Y, Haraoka J, Hirabayashi H, et al. A randomized controlled trial of hydrocortisone against hyponatremia in patients with aneurysmal subarachnoid hemorrhage. Stroke 2007;38:2373–5.PubMedCrossRef Katayama Y, Haraoka J, Hirabayashi H, et al. A randomized controlled trial of hydrocortisone against hyponatremia in patients with aneurysmal subarachnoid hemorrhage. Stroke 2007;38:2373–5.PubMedCrossRef
12.
Zurück zum Zitat Mori T, Katayama Y, Kawamata T, Hirayama T. Improved efficiency of hypervolemic therapy with inhibition of naturesis by fludrocortisones in patients with aneurysmal subarchnoid hemorrhage. J Neurosurg. 1999;91:947–52.PubMed Mori T, Katayama Y, Kawamata T, Hirayama T. Improved efficiency of hypervolemic therapy with inhibition of naturesis by fludrocortisones in patients with aneurysmal subarchnoid hemorrhage. J Neurosurg. 1999;91:947–52.PubMed
13.
Zurück zum Zitat Lennihan L, Mayer SA, Fink ME, et al. Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage. Stroke 2000;31:383–91.PubMed Lennihan L, Mayer SA, Fink ME, et al. Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage. Stroke 2000;31:383–91.PubMed
14.
Zurück zum Zitat Ness PM, Kruskall MS. Principles of red blood cell transfusion. In: Hoffman K, editor. Hematology: basic principles and practice. 4th ed. Orlando, FL: Churchill Livingstone; 2005. Ness PM, Kruskall MS. Principles of red blood cell transfusion. In: Hoffman K, editor. Hematology: basic principles and practice. 4th ed. Orlando, FL: Churchill Livingstone; 2005.
15.
Zurück zum Zitat Tseng MY, Czosnyka M, Richards H, Pickard JD, Kirkpatrick PJ. Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial. Stroke 2005;36:1627–32.PubMedCrossRef Tseng MY, Czosnyka M, Richards H, Pickard JD, Kirkpatrick PJ. Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial. Stroke 2005;36:1627–32.PubMedCrossRef
16.
Zurück zum Zitat Naidech AM, Kreiter KT, Janjua N, et al. Phenytoin exposure is associated with functional and cognitive disability after subarachnoid hemorrhage. Stroke 2005;36:583–7.PubMedCrossRef Naidech AM, Kreiter KT, Janjua N, et al. Phenytoin exposure is associated with functional and cognitive disability after subarachnoid hemorrhage. Stroke 2005;36:583–7.PubMedCrossRef
18.
Zurück zum Zitat Kasuya H, Onda H, Yoneyama T, Sasaki T, Hori T. Bedside monitoring of circulating blood volume after subarachnoid hemorrhage. Stroke 2003;34:956–60.PubMedCrossRef Kasuya H, Onda H, Yoneyama T, Sasaki T, Hori T. Bedside monitoring of circulating blood volume after subarachnoid hemorrhage. Stroke 2003;34:956–60.PubMedCrossRef
19.
Zurück zum Zitat He YL, Tanigami H, Ueyama H, Mashimo T, Yoshiya I. Measurement of blood volume using indocyanine green measured with pulse-spectrophotometry: its reproducibility and reliability. Crit Care Med. 1998;26:1446–51.PubMedCrossRef He YL, Tanigami H, Ueyama H, Mashimo T, Yoshiya I. Measurement of blood volume using indocyanine green measured with pulse-spectrophotometry: its reproducibility and reliability. Crit Care Med. 1998;26:1446–51.PubMedCrossRef
20.
Zurück zum Zitat The National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med. 2006;354:2564–75.CrossRef The National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med. 2006;354:2564–75.CrossRef
Metadaten
Titel
Packed Red Blood Cell Transfusion Causes Greater Hemoglobin Rise at a Lower Starting Hemoglobin in Patients with Subarachnoid Hemorrhage
verfasst von
Andrew M. Naidech
Marc J. Kahn
Wayne Soong
David Green
H. Hunt Batjer
Thomas P. Bleck
Publikationsdatum
01.10.2008
Verlag
Humana Press Inc
Erschienen in
Neurocritical Care / Ausgabe 2/2008
Print ISSN: 1541-6933
Elektronische ISSN: 1556-0961
DOI
https://doi.org/10.1007/s12028-008-9113-8

Weitere Artikel der Ausgabe 2/2008

Neurocritical Care 2/2008 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.